Home › Functietitels › Regulatory Affairs Manager
Regulatory Affairs Manager: H-1B-salarissen
73 arbeidsvoorwaardenaanvragen gebruikten de functietitel Regulatory Affairs Manager. Mediaan aangeboden basissalaris $125.000; middenhelft $110.718–$142.184.
Aanvragen (LCA's)73
Mediaan aangeboden salaris$125.000
Middelste helft van salarissen$110.718–$142.184
10e–90e percentiel$94.702–$166.519
Immigratieadvocaat, recruiter of werkgever? Laat uw dienst bovenaan deze pagina zien — $99 voor 30 dagen →
Werkgevers
| Werkgever | LCAs | Mediaan salaris |
|---|
| Freyr,Inc. | 4 | $124.180 |
| Rising Pharma Holdings Inc. | 4 | $106.838 |
| Edenbridge Pharmaceuticals, LLC | 3 | $125.000 |
| Roche Sequencing Solutions, Inc. | 3 | $140.504 |
| Withings, Inc. | 3 | $117.000 |
| Galt Pharmaceuticals, LLC | 3 | $95.472 |
| Rentschler Biopharma, Inc. | 2 | $140.000 |
| Teva Pharmaceuticals USA, Inc. | 2 | $116.866 |
| Becton, Dickinson and Company | 2 | $170.000 |
| Siemens Medical Solutions USA, Inc. | 2 | $139.059 |
| St. Jude Medical, Cardiology Division, Inc. | 2 | $117.855 |
| Inari Medical, Inc. | 2 | $173.043 |
| Zimmer, Inc. | 2 | $135.466 |
| Kerry Inc. | 2 | $132.862 |
| Long Shine LLC | 2 | $84.000 |
| PAI Holdings LLC | 2 | $106.392 |
| Instrumentation Laboratory Company | 1 | $150.176 |
| ForDoz Pharma Corp | 1 | $114.999 |
| August Bioservices, LLC | 1 | $74.318 |
| Evergreen Theragnostics, Inc. | 1 | $115.000 |
| Azurity Pharmaceuticals, Inc. | 1 | $145.000 |
| Medtronic, Inc. | 1 | $99.736 |
| Think Logic Systems Inc | 1 | $120.640 |
| Hetero USA Inc. | 1 | $185.000 |
| AMP Solutions LLC | 1 | $109.824 |
| Planet Innovation, Inc. | 1 | $140.000 |
| Cornerstone Medical (USA) Inc. | 1 | $155.000 |
| Applied Medical Resources Corporation | 1 | $128.000 |
| Ascensia Diabetes Care US Inc. | 1 | $144.891 |
| Bio-Rad Laboratories, Inc. | 1 | $155.000 |
| RK Pharma Inc | 1 | $140.483 |
| AstraZeneca Pharmaceuticals LP | 1 | $127.694 |
| New York City Criminal Justice Agency, Inc. | 1 | $102.315 |
| NeoImmuneTech, Inc. | 1 | $131.250 |
| BioPathogenix LLC. | 1 | $100.000 |
| Arteriocyte Medical Systems, Inc. | 1 | $128.205 |
| Prestonwood Home Healthcare LLC | 1 | $87.776 |
| Carefirst Rehab, LLC | 1 | $62.941 |
| scPharmaceuticals Inc. | 1 | $120.640 |
| ND Global Consulting Services Inc. | 1 | $166.400 |
| Nevakar Injectables Inc. | 1 | $310.000 |
| Granules Pharmaceuticals Inc. | 1 | $82.000 |
| New Erie Scientific LLC | 1 | $114.750 |
| Ambio, Inc. | 1 | $75.000 |
| Bachem Americas, Inc. | 1 | $104.000 |
| Apyx Medical Corporation | 1 | $154.294 |
| Ortho-Clinical Diagnostics, Inc. | 1 | $100.464 |
| Endovascular Engineering | 1 | $168.064 |
| Guardant Health, Inc. | 1 | $135.678 |
Per loonniveau
| Loonniveau | Mediaan salaris |
|---|
| Niveau I (instap) | $108.675 |
| Niveau II (gekwalificeerd) | $129.625 |
| Niveau III (ervaren) | $155.000 |
| Niveau IV (volledig bekwaam) | $126.704 |
Het Department of Labor stelt vier heersende loonniveaus vast voor elk beroep en gebied, van Niveau I (instap) tot Niveau IV (volledig bekwaam). De werkgever kiest het niveau dat bij de vereisten van de baan past.
Per boekjaar
| Boekjaar | LCAs | Mediaan salaris |
|---|
| FY2023 | 25 | $125.000 |
| FY2024 | 21 | $123.110 |
| FY2025 | 19 | $120.000 |
| FY2026 | 5 | $127.555 |
Steden
- Parsippany, NJ4
- East Brunswick, NJ4
- Irvine, CA3
- San Jose, CA3
- Boston, MA3
- Milford, MA2
- Franklin Lakes, NJ2
- Malvern, PA2
- San Diego, CA2
- Atlanta, GA2
- Beloit, WI2
- Ontario, CA2
- Plainsboro, NJ2
- Bridgewater, NJ2
- Bedford, MA1
- East Windsor, NJ1
- Nashville, TN1
- Springfield, NJ1
- Old Bridge, NJ1
- Overland Park, KS1
- West Chester, PA1
- Danvers, MA1
- Alpharetta, GA1
- Piscataway, NJ1
- Charlotte, NC1
- Waltham, MA1
- Princeton, NJ1
- Maple Grove, MN1
- Rancho Santa Margarita, CA1
- Redmond, WA1
Salarissen zijn het laagste eind van het aangeboden loon per aanvraag, omgerekend naar een jaarbedrag; statistieken gebruiken alleen gecertificeerde fulltime aanvragen. Een LCA is geen visumgoedkeuring en één LCA kan meerdere functies dekken. Bron: U.S. Department of Labor, OFLC LCA Disclosure Data, boekjaren 2023–2026 (laatste beslissing 30 jun. 2026).